GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 5901 - 5950 of 39437 in total
PDB ID UniProt ID Title Descriptor ▼
3OV6 P29017 CD1c in complex with MPM (mannosyl-beta1-phosphomycoketide) Beta-2-microglobulin, T-cell surface glycoprotein CD1c, T-cell surface glycoprotein CD1b
4OOZ B4XC07 Crystal structure of beta-1,4-D-mannanase from Cryptopygus antarcticus in complex with mannopentaose Beta-1,4-mannanase (E.C.3.2.1.78)
5M60 D8UU87 Chaetomium thermophilum beta-1-3-glucanase Beta-1,3-glucanase
3OTK Q09324 Structure and mechanisim of core 2 beta1,6-n-acetylglucosaminyltransferase: a Metal-ion independent gt-a glycosyltransferase Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (E.C.2.4.1.102)
3UTW P02945 Crystal structure of bacteriorhodopsin mutant P50A/Y57F Bacteriorhodopsin
2YQ2 2YQ2 Structure of BVDV1 envelope glycoprotein E2, pH8 BVDV1 E2
6HZE 6HZE BP0997, GH138 enzyme targeting pectin rhamnogalacturonan II BPa0997
1LXI P18075 Refinement of BMP7 crystal structure BONE MORPHOGENETIC PROTEIN 7
1DAN P08709 Complex of active site inhibited human blood coagulation factor VIIA with human recombinant soluble tissue factor BLOOD COAGULATION FACTOR VIIA, SOLUBLE TISSUE FACTOR, D-PHE-PHE-ARG-CHLOROMETHYLKETONE (DFFRCMK) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP, METHYLENE GROUP
1DAN P13726 Complex of active site inhibited human blood coagulation factor VIIA with human recombinant soluble tissue factor BLOOD COAGULATION FACTOR VIIA, SOLUBLE TISSUE FACTOR, D-PHE-PHE-ARG-CHLOROMETHYLKETONE (DFFRCMK) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP, METHYLENE GROUP
6VFL 6VFL BG505-SOSIP model reconstructed by subparticle extraction and refinement from a tetrahedral nanoparticle T33_dn10 BG505-SOSIPv5.2(7S) - gp120, BG505-SOSIPv5.2(7S) - gp41
6V0R Q2N0S6 BG505 SOSIP.664 Trimer BG505 SOSIPv5.2 gp120, BG505 SOSIPv5.2 gp41
6VL5 6VL5 BG505 SOSIP reconstructed from a designed tetrahedral nanoparticle, BG505 SOSIP-T33_dn2 BG505 SOSIP.v5.2(7S) - gp120, BG505 SOSIP.v5.2(7S) - gp41
5I8H Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer in Complex with V3 Loop-targeting Antibody PGT122 Fab and Fusion Peptide-targeting Antibody VRC34.01 Fab BG505 SOSIP.664 gp120, BG505 SOSIP.664 gp41, PGT122 Fab light chain, VRC34.01 Fab heavy chain, VRC34.01 Fab light chain, PGT122 Fab heavy chain
5I8H 5I8H Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer in Complex with V3 Loop-targeting Antibody PGT122 Fab and Fusion Peptide-targeting Antibody VRC34.01 Fab BG505 SOSIP.664 gp120, BG505 SOSIP.664 gp41, PGT122 Fab light chain, VRC34.01 Fab heavy chain, VRC34.01 Fab light chain, PGT122 Fab heavy chain
1C1Z 28810 CRYSTAL STRUCTURE OF HUMAN BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H) BETA2-GLYCOPROTEIN-I
1O7A P07686 Human beta-Hexosaminidase B BETA-HEXOSAMINIDASE BETA CHAIN (E.C.3.2.1.52)
1BHG P08236 HUMAN BETA-GLUCURONIDASE AT 2.6 A RESOLUTION BETA-GLUCURONIDASE
1UYQ P22073 mutated b-glucosidase A from Paenibacillus polymyxa showing increased stability BETA-GLUCOSIDASE A (E.C.3.2.1.21)
1E1F P49235 Crystal structure of a Monocot (Maize ZMGlu1) beta-glucosidase in complex with p-Nitrophenyl-beta-D-thioglucoside BETA-GLUCOSIDASE (E.C.3.2.1.21)
3ZYZ Q12715 Crystal structure of a glycoside hydrolase family 3 beta-glucosidase, Bgl1 from Hypocrea jecorina at 2.1A resolution. BETA-D-GLUCOSIDE GLUCOHYDROLASE (E.C.3.2.1.21)
3ZZ1 Q12715 Crystal structure of a glycoside hydrolase family 3 beta-glucosidase, Bgl1 from Hypocrea jecorina at 2.1A resolution. BETA-D-GLUCOSIDE GLUCOHYDROLASE (E.C.3.2.1.21)
1BTC P10538 THREE-DIMENSIONAL STRUCTURE OF SOYBEAN BETA-AMYLASE DETERMINED AT 3.0 ANGSTROMS RESOLUTION: PRELIMINARY CHAIN TRACING OF THE COMPLEX WITH ALPHA-CYCLODEXTRIN BETA-AMYLASE (E.C.3.2.1.2) COMPLEX WITH ALPHA-CYCLODEXTRIN (ALPHA-14-MALTOHYDROLASE)
2CDO 2CDO structure of agarase carbohydrate binding module in complex with neoagarohexaose BETA-AGARASE 1
2CDO Q6DN99 structure of agarase carbohydrate binding module in complex with neoagarohexaose BETA-AGARASE 1
2CDO 2CDO structure of agarase carbohydrate binding module in complex with neoagarohexaose BETA-AGARASE 1
2CDO Q6DN99 structure of agarase carbohydrate binding module in complex with neoagarohexaose BETA-AGARASE 1
1FIZ P08001 THREE DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM BOAR SPERMATOZOA BETA-ACROSIN HEAVY CHAIN/BETA-ACROSIN LIGHT CHAIN
1FIW Q9GL10 THREE-DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM RAM SPERMATOZOA BETA-ACROSIN (E.C.3.4.21.10)
1FIW 1FIW THREE-DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM RAM SPERMATOZOA BETA-ACROSIN (E.C.3.4.21.10)
1FH7 144429 CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED INHIBITOR DEOXYNOJIRIMYCIN BETA-1,4-XYLANASE (E.C.3.2.1.91)
1FH8 144429 CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED ISOFAGOMINE INHIBITOR BETA-1,4-XYLANASE (E.C.3.2.1.91)
1FH9 144429 CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED LACTAM OXIME INHIBITOR BETA-1,4-XYLANASE (E.C.3.2.1.91)
1FHD 144429 CRYSTAL STRUCTURE OF THE XYLANASE CEX WITH XYLOBIOSE-DERIVED IMIDAZOLE INHIBITOR BETA-1,4-XYLANASE (E.C.3.2.1.91)
1HJS 1HJS Structure of two fungal beta-1,4-galactanases: searching for the basis for temperature and pH optimum. BETA-1,4-GALACTANASE (E.C.3.2.1.89)
1HJU 1HJU Structure of two fungal beta-1,4-galactanases: searching for the basis for temperature and pH optimum. BETA-1,4-GALACTANASE (E.C.3.2.1.89)
1EXP 144429 BETA-1,4-GLYCANASE CEX-CD BETA-1,4-D-GLYCANASE CEX-CD
1C1J P04417 STRUCTURE OF CADMIUM-SUBSTITUTED PHOSPHOLIPASE A2 FROM AGKISTRONDON HALYS PALLAS AT 2.8 ANGSTROMS RESOLUTION BASIC PHOSPHOLIPASE A2 (E.C.3.1.1.4)
1GO6 NOR00709 Balhimycin in complex with Lys-D-ala-D-ala BALHIMYCIN, PEPTIDE LYS-DAL-DAL
1GO6 1GO6 Balhimycin in complex with Lys-D-ala-D-ala BALHIMYCIN, PEPTIDE LYS-DAL-DAL
4JNO Q8T9N3 Crystal structure of Plasmodium falciparum Erythrocyte Binding Antigen 140 (PfEBA-140/BAEBL) Region II in complex with sialyllactose BAEBL protein
1DZE P02945 Structure of the M Intermediate of Bacteriorhodopsin trapped at 100K BACTERIORHODOPSIN (M INTERMEDIATE)
5VL3 S6B291 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 5VL3 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 S6B291 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 5VL3 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 Q8TCD0 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 Q8TCD0 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
5VL3 P20273 CD22 d1-d3 in complex with therapeutic Fab Epratuzumab B-cell receptor CD22, Epratuzumab Fab Heavy Chain,Epratuzumab Fab Heavy Chain, Epratuzumab Fab Light Chain,Epratuzumab Fab Light Chain
1LDQ P02701 avidin-homobiotin complex Avidin

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024